LIQUIDIA 26.5 Pill - yellow clear capsule/oblong
Generic Name: treprostinil
Pill with imprint LIQUIDIA 26.5 is Yellow / Clear, Capsule/Oblong and has been identified as Yutrepia 26.5 mcg (for oral inhalation). It is supplied by Liquidia Technologies, Inc.
Yutrepia is used in the treatment of Pulmonary Arterial Hypertension and belongs to the drug class agents for pulmonary hypertension. treprostinil (Remodulin, Tyvaso): There is no proven risk in humans during pregnancy. treprostinil oral (Orenitram): Risk cannot be ruled out during pregnancy. Yutrepia 26.5 mcg (for oral inhalation) is not a controlled substance under the Controlled Substances Act (CSA).
Images for LIQUIDIA 26.5
Yutrepia
- Generic Name
- treprostinil
- Imprint
- LIQUIDIA 26.5
- Strength
- 26.5 mcg (for oral inhalation)
- Color
- Yellow / Clear (opaque yellow cap, clear body)
- Shape
- Capsule/Oblong (capsule)
- Availability
- Prescription only
- Drug Class
- Agents for pulmonary hypertension
- Pregnancy Category
- B - No proven risk in humans - treprostinil (Remodulin, Tyvaso), C - Risk cannot be ruled out - treprostinil oral (Orenitram)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Liquidia Technologies, Inc.
- National Drug Code (NDC)
- 72964-0011
See also:
More about Yutrepia (treprostinil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: agents for pulmonary hypertension
- Breastfeeding
Patient resources
Other brands
Remodulin, Tyvaso, Orenitram, Tyvaso DPI
Professional resources
Other brands
Remodulin, Tyvaso, Orenitram, Tyvaso DPI
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.